General practitioner outreach to boost cervical cancer screening participation
Official title: Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening
Run by Centre Hospitalier Intercommunal Creteil · NCT06527456 · Data updated 2026-11-12
This project will test whether outreach from a general practitioner (phone, SMS, or email) helps women aged 25–65 in Île‑de‑France who are overdue for cervical screening to book and attend screening.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 65 Years |
| Sex | All |
| Enrollment | 11200 (estimated) |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Locations | 1 site (Créteil) |
| Status | Recruiting |
| Started | January 21, 2026 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | April 14, 2026 |
| Trial ID | NCT06527456 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 25 to 65 living in Île‑de‑France who are eligible for the DOCCU program, not up to date with cervical screening, and registered with a participating general practitioner in the UPEC CPTS area.
✕Probably not a fit
Patients who are already up to date with screening, have had a hysterectomy, are under active follow-up for cervical precancer or cancer, or explicitly refuse participation are unlikely to benefit from this outreach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a cluster-randomized trial that randomizes GP practices in the UPEC/Créteil area to either usual care or an intervention where the GP or their team contacts overdue patients by phone, SMS, email, or other means to encourage screening. Randomization at the practice level reduces contamination between clinicians in the same office. The main outcome is participation in the national organized screening program (DOCCU) among women not up to date with screening. Contact methods and timing are left to each GP’s discretion, and inclusion is limited to women aged 25–65 who are eligible for DOCCU and registered with participating GPs.
Why it matters
Potential benefit: If successful, the intervention could increase screening participation and lead to earlier detection and fewer advanced cervical cancers.
How similar studies have gone: Previous reminder and provider‑outreach studies have generally produced modest to moderate increases in screening uptake, so this intervention builds on established approaches.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Woman aged 25 to 65 living in Ile-De-France * Eligible for DOCCU (not hysterectomized, not followed for a pre-cancerous or cancerous lesion of the cervix) * Having declared the investigating general practitioner as a treating physician (MT) and whose MT practices in the territory of a CPTS in the UPEC area * Affiliate to a social security scheme or beneficiary of such a scheme Exclusion Criteria: * Patient already included in a study on DOCCU * Patient excluded from organized screening (cervical cancer, hysterectomy). * Patient's opposition to participating in the study
Where it's running
-
Médecins généralistes dans le bassin de l'UPEC
Créteil, France Recruiting
Study contacts
- Study coordinator: Emilie FERRAT
- Email: emilie.ferrat@u-pec.fr
- Phone: 0633085225
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cervical screening and care options for women living with HIV who test positive for high-risk HPV
This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.
-
Hydrogel spacer to protect the rectum during cervical cancer radiotherapy
This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.
-
How cinema sessions during chemotherapy might help cervical cancer patients
We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.